ACTA2 and liver cancer: Recent studies revealed that dysregulation of ACTA2-AS1 has been found to be closely related to poor prognosis of several cancers, such as cervical cancer, hepatocellular carcinoma, liver cancer, breast cancer and lung adenocarcinoma [13–15].